|
News FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies
The U.S. Food and Drug Administration (FDA) is updating the public on the use of selective serotonin reuptake inhibitor (SSRI) antidepressants by women during pregnancy and the potential risk of a rare heart and lung condition known as persistent pulmonary hypertension of the newborn (PPHN). |
|
Leaflet Drug Ciclosporin (inhalation use)
Ciclosporin (inhalation use) for the prevention of graft rejection after lung transplantation. |
|
Article Pulmonary Hypertension
Pulmonary hypertension is high blood pressure in the arteries to your lungs. It is a serious condition for which there are treatments but no cure. |
|
Article Pulmonary Hypertension Association
Our mission is to find ways to prevent and cure pulmonary hypertension, and to provide hope for the pulmonary hypertension community through support, education, advocacy and awareness. |
